Yahoo
NasdaqCM - Delayed Quote USD

EUDA Health Holdings Limited (EUDA)

13.51 -1.52 (-10.11%)
At close: November 6 at 4:00:01 PM EST
Chart Range Bar
Loading chart for EUDA
  • Previous Close 15.03
  • Open 15.35
  • Bid 13.90 x 1400
  • Ask 14.30 x 1300
  • Day's Range 13.51 - 16.01
  • 52 Week Range 5.26 - 70.00
  • Volume 28,841
  • Avg. Volume 31,035
  • Market Cap (intraday) 40.453M
  • Beta (5Y Monthly) 0.55
  • PE Ratio (TTM) --
  • EPS (TTM) -1.16
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 55.00
  • Moby Rating Neutral

EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services. The company also provides property management services. The company was founded in 2019 and is headquartered in Singapore.

eudahealth.com

123

Full Time Employees

December 31

Fiscal Year Ends

Real Estate

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

EUDA
70.76%
S&P 500 (^GSPC)
7.76%

1-Year Return

EUDA
77.63%
S&P 500 (^GSPC)
9.77%

3-Year Return

EUDA
51.40%
S&P 500 (^GSPC)
68.96%

5-Year Return

EUDA
93.00%
S&P 500 (^GSPC)
57.04%

Analyst Insights

View More

Analyst Price Targets

55.00
55.00 Average
13.51 Current
55.00 High

Latest Rating

Date 3/9/2026
Analyst Greenridge Global
Rating Action Maintains
Rating Buy
Price Action Lowers
Price Target 6 -> 2.75

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -32.69%

  • Return on Assets (ttm)

    -21.92%

  • Return on Equity (ttm)

    -211.36%

  • Revenue (ttm)

    7.23M

  • Net Income Avi to Common (ttm)

    -2.36M

  • Diluted EPS (ttm)

    -1.16

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    365.9k

  • Total Debt/Equity (mrq)

    5.70%

  • Levered Free Cash Flow (ttm)

    -8.8M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: